After being dehydrogenated by cytochrome P450 enzymes in the liver, monocrotaline's highly-reactive pyrrole metabolite, dehydromonocrotaline, is believed to interact with pulmonary artery endothelial cells to initiate a pulmonary vascular toxicity resembling pulmonary hypertension. Glutathione, an abundant antioxidant in pulmonary artery endothelial cells, has been shown to react with and detoxify the pyrrolic metabolites derived from monocrotaline in the liver. Using high-performance liquid chromatography with electrochemical detection, glutathione levels were measured in a time- and dose-dependent manner in human pulmonary artery endothelial cells following treatment with dehydromonocrotaline, dehydroretronecine and N-ethylmaleimide and bovine pulmonary artery endothelial cells after treatment with dehydromonocrotaline. The bovine cells had 40% less glutathione than the human in the control groups. Bovine pulmonary artery endothelial glutathione levels were depleted 20% more than the human at 15 minutes when treated with 100 μM dehydromonocrotaline. 15μM N-ethylmaleimide caused an 80% depletion of glutathione compared to a 30% depletion with 15μM dehydromonocrotaline in human pulmonary artery endothelial cells.
|Original language||English (US)|
|Number of pages||16|
|Journal||Research Communications in Molecular Pathology and Pharmacology|
|State||Published - 1998|
ASJC Scopus subject areas
- Pharmacology, Toxicology and Pharmaceutics(all)
- Pathology and Forensic Medicine